Crinetics Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: CRNX
Share price (8/6/26): $83.92
Market cap (8/6/26): $8.901 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Farallon Capital Management, L.L.C.

Vivaldi Coelho Rogerio

Vivaldi Coelho Rogerio

News Filter

Reports Second Quarter 2026 Financial Results and Provides Business Update

Material Definitive Agreement, Change in Directors, Officers or Compensation

Vertex to Acquire Crinetics Pharmaceuticals

Shareholder Vote Results

Reports First Quarter 2026 Financial Results and Provides Business Update

Proxies Filter

Proxy related to merger

Preliminary proxy related to merger

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC